Home/Filings/4/0001185185-17-001923
4//SEC Filing

Comella Kristin C 4

Accession 0001185185-17-001923

CIK 0001388319other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:03 PM ET

Size

7.6 KB

Accession

0001185185-17-001923

Insider Transaction Report

Form 4
Period: 2017-08-07
Comella Kristin C
Chief Science Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-07+7,500,00019,197,746 total
    Exercise: $0.03Exp: 2027-08-07Common Stock (7,500,000 underlying)
  • Award

    Stock Option (right to buy)

    2017-08-07+1,500,00020,697,746 total
    Exercise: $0.03From: 2017-08-07Exp: 2027-08-07Common Stock (1,500,000 underlying)
Footnotes (1)
  • [F1]1,875,000 vest on 08/07/2018, 1,875,000 vest on 08/07/2019, 1,875,000 vest on 08/07/2020, 1,875,000 vest on 08/07/2021.

Issuer

U.S. Stem Cell, Inc.

CIK 0001388319

Entity typeother

Related Parties

1
  • filerCIK 0001465760

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:03 PM ET
Size
7.6 KB